BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3697936)

  • 21. A quantitative study of alpha-naphthyl acetate esterase-positive cells in non-Hodgkin's lymphomas and reactive lymph nodes.
    Crocker J; Jones EL; Curran RC
    J Clin Pathol; 1982 Oct; 35(10):1066-8. PubMed ID: 7130417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-Hodgkin's lymphoma classification: ultrastructural morphometric studies for the quantification of nuclear compartments in situ.
    Dardick I; Dardick AM; Caldwell DR; Jeans MT; Bladon T; Setterfield G
    Hum Pathol; 1985 Oct; 16(10):1047-60. PubMed ID: 4043954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomorphologic characteristics of non-Hodgkin's lymphoma.
    Bizjak-Schwarzbartl M
    Acta Cytol; 1988; 32(2):216-20. PubMed ID: 2450436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.
    Macartney JC; Camplejohn RS; Alder J; Stone MG; Powell G
    J Clin Pathol; 1986 May; 39(5):542-6. PubMed ID: 3722408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear morphologic and morphometric analyses of large noncleaved cell and immunoblastic non-Hodgkin's lymphomas.
    Dardick I; Caldwell DR; McCaughey WT; Al-Jabi M
    Hum Pathol; 1984 Oct; 15(10):965-72. PubMed ID: 6548202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
    Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
    Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
    Wessel H
    Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
    Weisenburger DD
    Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
    Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasia.
    Mazur G; Haloń A; Wróbel T; Urbaniak J; Kuliczkowski K; Woźniak M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():76-8. PubMed ID: 15638381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow analysis of DNA content and cell size in non-Hodgkin's lymphoma.
    Diamond LW; Braylan RC
    Cancer Res; 1980 Mar; 40(3):703-12. PubMed ID: 7471089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testicular lymphomas: a clinicopathologic study of 35 cases.
    Turner RR; Colby TV; MacKintosh FR
    Cancer; 1981 Nov; 48(9):2095-102. PubMed ID: 7296517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification.
    Musshoff K; Schmidt-Vollmer H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Aug; 83(4):323-41. PubMed ID: 125960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
    Ding SL; Ko WS; Hwang WS
    J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of cytophotometric analysis of DNA in lymph node aspirates from patients with non-Hodgkin's lymphoma.
    Vucković J; Dubravcić M; Matthews JM; Wickramasinghe SN; Dominis M; Jaksić B
    J Clin Pathol; 1990 Aug; 43(8):626-9. PubMed ID: 2401729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar organizer regions in lymphomas: a quantitative study.
    Yekeler H; Ozercan MR; Yumbul AZ; Ağan M; Ozercan IH
    Pathologica; 1993; 85(1097):353-60. PubMed ID: 8233651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.